On January 24, 2026, Xinyan Medical successfully held the "Together in Heart, Innovating for the Future — Wearable 12-Lead ECG Monitoring Device Launch Event" at the Ningbo Lianyong Shuichiao Exhibition Hall. The event was organized to express sincere appreciation to core distribution partners for their long-term support during the product registration process and to officially announce the market launch of Xinyan Medical's newly approved wearable 12-lead ECG monitoring device, which has obtained the National Medical Device Registration Certificate.
Senior management of Xinyan Medical, representatives from R&D and marketing teams, invited medical experts, academicians, and key distributors from across China gathered to explore the future of ECG monitoring technology and collaborative innovation.
The event began in a professional and welcoming atmosphere. Guests were guided to visit the Smart Health City Reception Hall, gaining insights into Xinyan Medical's strategic vision and long-term commitment to smart healthcare and health technology innovation.
Guests exploring the Smart Health City Reception Hall at Xinyan Medical's launch event
The main launch ceremony was held in the fourth-floor conference hall. Xinyan Medical's leadership delivered an opening address, reflecting on the challenging journey from product development and clinical validation to regulatory approval, and expressing heartfelt gratitude to distribution partners for their continued trust and support. A formal unveiling ceremony of the medical device registration certificate followed, marking a significant milestone in the company's development.
The formal unveiling ceremony of the medical device registration certificate
During the product presentation session, the Head of Marketing provided a comprehensive introduction to the wearable 12-lead ECG monitoring device through presentations and live demonstrations, highlighting its key advantages in technological innovation, clinical application, and patient-centered value. The Head of R&D then shared insights into the core technical breakthroughs and development process, as well as the company's future product roadmap, further strengthening partners' confidence.
Detailed product presentation showcasing technological innovations
The event also featured expert presentations from leading cardiovascular clinicians, who discussed the clinical significance of wearable ECG monitoring in diagnosis, disease management, and long-term health monitoring.
Academician Deshuang Huang from Eastern Institute of Technology delivered a keynote speech on AI applications in biological data, offering a forward-looking academic perspective on the intelligent development of ECG monitoring technologies.
Academician Deshuang Huang sharing insights on "AI Applications in Biological Data"
In the "Win-Win Partnership Strategy Release" session, Xinyan Medical officially announced its 2026 distributor support policies, outlining clear market strategies and collaboration mechanisms to accelerate large-scale market adoption.
The comprehensive policy framework focuses on empowering distribution partners through enhanced technical support, marketing resources, and collaborative business development initiatives.
Following the conference, guests were invited to the product experience area for hands-on demonstrations and in-depth discussions. Xinyan Medical's technical and sales teams provided on-site support, creating an active and engaging atmosphere.
Product experience area: Guests engaging with Xinyan Medical's technical team
The successful launch event not only marks the official market entry of Xinyan Medical's wearable 12-lead ECG monitoring device, but also reinforces strong partnerships with distributors nationwide.
Looking ahead to 2026, Xinyan Medical will continue to drive innovation through technology and build bridges through collaboration, working closely with partners to advance ECG health management and deliver greater value to patients worldwide.